Samsung Bio secures $1.3B contract with ‘large-sized’ US pharma customer

Samsung Bio secures $1.3B contract with ‘large-sized’ US pharma customer

Samsung Biologics has pulled in another billion dollar contract, this time with an unnamed “large-sized” US pharma company. The $1.3 billion contract started on Aug. 29 and will run until the end of 2029, Samsung ...

Samsung Biologics Secures 1.8 Tril. Won Mega Contract with U.S. Pharma Company

Samsung Biologics facility in Songdo, Incheon (Photo courtesy of Samsung Biologics) Samsung Biologics has secured a massive contract manufacturing organization (CMO) contract worth 1.8 trillion won with a U.S. pharmaceutical company, despite the pressure of U.S. tariffs dampening the export environment to America. This is the second-largest order following the 2.0747 trillion won contract from a European pharmaceutical company in January this ye…